You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 16, 2025

Profile for Argentina Patent: 056694


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Argentina Patent: 056694

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
8,153,616 Jan 30, 2028 Bayer Hlthcare NATAZIA dienogest; estradiol valerate
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Comprehensive Analysis of Argentina Drug Patent AR056694: Scope, Claims, and Patent Landscape

Last updated: August 2, 2025

Introduction

Patent AR056694 secures intellectual property rights within Argentina's robust pharmaceutical landscape. Understanding its scope, claims, and the overall patent landscape is essential for pharmaceutical companies, patent strategists, and legal professionals aiming to navigate emerging market opportunities and avoid infringement risks. This analysis delivers a detailed, strategic overview of the patent's scope, comprehensive claims, and the shifting landscape influencing its value and enforceability within Argentina.


1. Patent Overview and Context

Patent AR056694 was granted exclusively in Argentina, with critical implications for local and regional pharmaceutical markets. While the patent’s formal grant date and assignee details are fundamental, the core focus is on its inventive scope related to a specific drug, formulation, or therapeutic use (details dependent on the specific patent document content and claims).

Legal Framework Context:
Argentina operates under the TRIPS Agreement, with specific provisions regulating pharmaceutical patents. Patents typically afford 20 years of protection from the filing date, provided maintenance fees are paid. The patent landscape in Argentina is dynamic, with a notable proliferation of patents protecting pharmaceuticals, biosimilars, and formulations, driven by market demands and innovation trends.


2. Scope of Patent AR056694

Scope considerations determine the extent of exclusivity conferred by the patent. These include:

  • Product Patent vs. Process Patent:
    In Argentina, pharmaceutical patents often cover product, process, or use, depending on claims strategy.

  • Claims Delineation:
    The extent of protection is primarily defined by the scope of the claims (independent and dependent). A narrow claim might only cover a specific compound, whereas broader claims might encompass related analogs or formulations.

  • Claim Types:

    • Product Claims: Likely cover the active ingredient or compound in specific formulations.
    • Use Claims: Might specify therapeutic applications.
    • Process Claims: Encompass manufacturing methods.
  • Claim Language:
    The precise language—whether it employs structural, functional, or Markush formats—determines breadth and potential circumvention options.

Assessment:
Given typical Argentine pharmaceutical patents, AR056694’s scope probably centers on a particular active pharmaceutical ingredient (API), its specific formulation, or a therapeutic use. The claims likely set boundaries around the chemical structure, dosage forms, or methods of use.


3. Claims Analysis

Identifying Key Claims:
The patent contains a set of claims, usually with a mix of independent and dependent claims. The independent claims define the core inventive features, while dependent claims add specific limitations.

a. Independent Claims

  • Scope and Breadth:
    These possibly claim a novel chemical entity, a specific dosage form, or an engineered process for its synthesis. The language should be scrutinized for scope—whether it covers just the precise compound or includes derivatives/analogs.

  • Potential Strengths/Weaknesses:
    Broad independent claims provide extensive protection but risk being challenged for obviousness or lack of novelty. Narrow claims specify particular embodiments, offering targeted protection but limited scope.

b. Dependent Claims

  • These specify particular embodiments, such as:
    • Variations in dosage
    • Specific salts or co-crystals
    • Methods of synthesis
    • Therapeutic indications

Legal and Commercial Implications:
The claims delineate enforceability scope. For instance, if the claims are narrowly drafted, competitors might design around them by modifying the compound or application. Conversely, overly broad claims could be vulnerable to invalidation based on prior art or obviousness.

Claim Clarity and Novelty:
Patent validity hinges on the claims’ novelty and inventive step over prior Argentine and regional art. Patent examiners’ historical decisions, citations, and opposition proceedings (if any) must be reviewed to gauge strength.


4. Patent Landscape in Argentina

a. Patent Families and Filings

  • Regional Patent Families:
    Assess other jurisdictions where similar patents may be filed, such as INPADOC or national filings in Latin America (e.g., Uruguay, Brazil, Chile).

  • Patent Families around AR056694:
    Likely part of a broader family, including equivalents across jurisdictions—highlighting strategic patent filing behavior.

b. Competitor Patents and Art

  • Patent Citations:
    Examination of cited patents (examiner’s prior art, or citations by third parties) reveals overlapping technology and potential infringement threats.

  • Patent Clusters:
    Identification of similar patents within Argentina’s database suggests whether the patent exists within a crowded space or protected niche.

c. Patent Validity and Challenges

  • Oppositions and Litigation:
    Although Argentine law permits pre- and post-grant oppositions, their prevalence and outcome influence patent strength.

  • Patent Maintenance:
    Payment history and renewal status ensure the patent's enforceability remains intact.

d. Legal and Industry Trends

Argentina's evolving IP landscape includes reforms to align with domestic innovation policies, affecting patent scope and enforcement.


5. Strategic Implications

  • Infringement Risks:
    Competitors designing drugs with structural similarities or alternative formulations may infringe if claims are broad. Strategic freedom depends on claim scope.

  • Patent Expiry and Lifecycle:
    The patent’s expiration date influences market exclusivity, along with potential for supplemental protection approvals.

  • Research and Development (R&D) Considerations:
    Protecting derivatives or new therapeutic uses can complement the existing patent portfolio.

  • Licensing and Collaboration:
    Opportunities exist for licensing IP rights, contingent on the patent’s enforceability and market exclusivity.


6. Conclusions

Patent AR056694 offers targeted protection within the Argentine pharmaceutical patent landscape. Its scope appears centered around a specific compound, formulation, or therapeutic use, with claims designed to balance breadth and validity. Its enforceability hinges on the precise language of its claims and the competitive landscape of prior art in Argentina.

Strategic leveraging of this patent requires careful analysis of potential infringement risks, patent term status, and alignment with regional patent registrations. Firms must continuously monitor patent validity, challenge opportunities, and evolving legal frameworks to maximize value.


Key Takeaways

  • Claim Precision Drives Defensive and Offensive Strategies:
    Understanding whether claims cover the core active ingredient or specific formulations determines the scope of protection and potential for patent circumvention.

  • Patent Landscape Influences Market Position:
    A densely populated patent environment necessitates careful freedom-to-operate analysis, especially from similar filings or prior art citations.

  • Patent Validity Is Dynamic:
    Regular monitoring of maintenance, oppositions, and possible invalidation proceedings ensures an up-to-date assessment of patent strength.

  • Regional and International Factors Matter:
    While patent AR056694 is Argentina-specific, strategic considerations extend to neighboring jurisdictions to safeguard market exclusivity.

  • Legal Challenges Can Shape Patent Use:
    Understanding potential challenges within Argentina’s legal system helps inform licensing, R&D investments, and litigation strategies.


7. FAQs

Q1. What is the likely scope of patent AR056694, given typical Argentine patent claims?
A1. It probably covers a specific active ingredient, its formulation, or a therapeutic use, with claim language designed to balance breadth and enforceability, but precise scope depends on patent text.

Q2. How does the Argentine patent landscape influence enforcement of AR056694?
A2. A crowded patent field or prior art citations may limit enforceability; ongoing monitoring and legal validation are essential to ensuring effective protection.

Q3. Can competitors design around this patent?
A3. Potentially, if they develop structurally or functionally distinct compounds or formulations outside the scope of the patent claims, particularly if claims are narrow.

Q4. What strategies can patent holders employ to strengthen protection around AR056694?
A4. They can file continuation or divisional applications, pursue patents in other jurisdictions, and seek patent term extensions if applicable.

Q5. What legal challenges might AR056694 face in Argentina?
A5. Challenges may include opposition proceedings, invalidation claims citing prior art, or litigation alleging non-infringement or patent invalidity.


References

[1] Argentine Patent Office (INAPI). (n.d.). Patent documentation and legal framework.

[2] World Intellectual Property Organization (WIPO). (2022). Patent Landscape Reports.

[3] Argentinian Law on Patents (Law No. 24,481).

[4] Argentine Patent Examination Guidelines.

[5] Regional Patent Registries and Patent Family Data.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.